Brainsway Ltd.
BWAY Nasdaq· Surgical & Medical Instruments & Apparatus
KIRA · Stoqly’s AI analyst, in plain words
- Brainsway Ltd. had $52.2M of revenue in fiscal 2025, up 27.3% on the year before. Over five years, revenue changed +18.8% a year on average.
- Its operating margin was 8.3%, up 4.9 pts: of every 100 in sales, about 8 is left after running the business.
- Brainsway Ltd. made $7.6M of net profit in fiscal 2025.
Market cap
—
P/E
—
Revenue
$52.2M
Net income
$7.6M
Free cash flow
—
Operating margin
8.3%
Brainsway Ltd. in 30 seconds · fiscal 2025
Are sales growing?
+27.3%
Yes. Sales grew 27.3% last year.
Does it make a profit?
14.5%
Yes. It keeps 14.5% of every sale as profit.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
What Brainsway Ltd. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 20, 2026
- Legal name
- Brainsway Ltd.
- CIK
- 0001505065
Brainsway Ltd. · BWAY
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $29.7M | $27.2M | $31.8M | $41.0M | $52.2M |
| Revenue growth | 34.5% | −8.4% | 17.0% | 29.0% | 27.3% |
| Gross margin | 77.7% | 73.8% | 73.9% | 74.6% | 75.4% |
| Operating margin | −16.9% | −46.7% | −15.6% | 3.4% | 8.3% |
| Net income | −$6.5M | −$13.3M | −$4.2M | $2.9M | $7.6M |
| Net margin | −21.8% | −49.1% | −13.2% | 7.1% | 14.5% |
| Diluted EPS | −$0.21 | −$0.40 | −$0.13 | $0.05 | $0.18 |
| Cash | |||||
| Cash from operations | $0.9M | −$9.8M | $1.3M | $10.3M | $17.5M |
| Capital expenditure | $2.2M | — | — | — | — |
| Free cash flow | −$1.4M | — | — | — | — |
| FCF margin | −4.6% | — | — | — | — |
| Share count change | 38.8% | 5.9% | 0.5% | 2.5% | 11.9% |
| Debt and strength | |||||
| Cash and short-term investments | $16.9M | $47.6M | $10.5M | $69.3M | $67.7M |
| Shareholders' equity | $57.3M | $45.4M | $41.6M | $62.3M | $73.2M |
| Current ratio | 7.2x | 7.1x | 5.7x | 5.2x | 3.7x |
| Interest coverage | — | −8.6x | −4.3x | 0.9x | 2.0x |
| Returns and quality | |||||
| Return on equity | −16.8% | −26.0% | −9.7% | 5.6% | 11.2% |
| Return on tangible equity | −11.3% | −29.4% | −10.1% | 4.7% | 10.4% |
| Piotroski F-score | 5 | 2 | 5 | 5 | 6 |
| Altman Z'' | 4.1 | 1.3 | 1.0 | 3.2 | 3.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Brainsway Ltd. · BWAY
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001505065). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.